Used in pharmaceutical research as a key intermediate in the development of kinase inhibitors, particularly for targeting enzymes involved in inflammatory and oncogenic pathways. Shows potential in the design of small-molecule therapeutics due to its ability to modulate protein activity through selective binding. Its structure supports optimization for improved metabolic stability and bioavailability in drug candidates. Investigated for use in treatments of cancers and autoimmune disorders where signal transduction modulation is critical. Also employed in structure-activity relationship (SAR) studies to enhance potency and selectivity of pyrimidine-based inhibitors.